A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

February 28, 2001

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

Travoprost

DRUG

Latanoprost

Trial Locations (1)

Latin America, Fort Worth